BioRider is a modular platform offering sustainable, affordable, flexible and reliable experimentation capabilities, enabling remote, in-situ biological research in space without the burden, complexity, or safety risks of human-attended operations. The facility is designed to operate aboard ESA’s Space Rider free-flyer vehicle and includes the recovery of biological samples exposed to microgravity. BioRider opens new opportunities for public and private researchers by streamlining access to microgravity, decoupling it from the need for crewed missions.
BioRider is a modular, standard, scalable, multi-user and re-usable facility that represents the perfect platform to perform life science experiments under microgravity conditions on board the Space Rider. It is:
Leveraging on the extensive experience of Kayser in the delivery of life science payloads in microgravity, BioRider is mainly dedicated to advancing biology and biotechnology R&D. It provides direct, simplified access to microgravity for both public and private researchers, avoiding complex and time-consuming bidding procedures. BioRider will fill the void left by the retirement of the ISS and its incubators, with the timely provision of flight opportunities starting as early as 2027 and not requiring the launch and commissioning of the new commercial space stations currently in the development phase.
Platform Design:
First Flight Booked: BioRider will fly aboard the maiden mission of ESA’s Space Rider in Q3 2027.
First Experiments Confirmed: The inaugural mission will host three experiments in distinct biological disciplines: astrobiology, developmental/cell biology, and nutrition/pharmacology.
For more information, reach out to Gianluca Neri, Programme Manager, Kayser Space Ltd. Email: info.biorider@kayser.it